Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Meta-analysis and imputation refines the association of 15q25 with smoking quantity.

Liu JZ, Tozzi F, Waterworth DM, Pillai SG, Muglia P, Middleton L, Berrettini W, Knouff CW, Yuan X, Waeber G, Vollenweider P, Preisig M, Wareham NJ, Zhao JH, Loos RJ, Barroso I, Khaw KT, Grundy S, Barter P, Mahley R, Kesaniemi A, McPherson R, Vincent JB, Strauss J, Kennedy JL, Farmer A, McGuffin P, Day R, Matthews K, Bakke P, Gulsvik A, Lucae S, Ising M, Brueckl T, Horstmann S, Wichmann HE, Rawal R, Dahmen N, Lamina C, Polasek O, Zgaga L, Huffman J, Campbell S, Kooner J, Chambers JC, Burnett MS, Devaney JM, Pichard AD, Kent KM, Satler L, Lindsay JM, Waksman R, Epstein S, Wilson JF, Wild SH, Campbell H, Vitart V, Reilly MP, Li M, Qu L, Wilensky R, Matthai W, Hakonarson HH, Rader DJ, Franke A, Wittig M, Schäfer A, Uda M, Terracciano A, Xiao X, Busonero F, Scheet P, Schlessinger D, St Clair D, Rujescu D, Abecasis GR, Grabe HJ, Teumer A, Völzke H, Petersmann A, John U, Rudan I, Hayward C, Wright AF, Kolcic I, Wright BJ, Thompson JR, Balmforth AJ, Hall AS, Samani NJ, Anderson CA, Ahmad T, Mathew CG, Parkes M, Satsangi J, Caulfield M, Munroe PB, Farrall M, Dominiczak A, Worthington J, Thomson W, Eyre S, Barton A; Wellcome Trust Case Control Consortium, Mooser V, Francks C, Marchini J.

Nat Genet. 2010 May;42(5):436-40. doi: 10.1038/ng.572. Epub 2010 Apr 25.

2.

Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior.

Thorgeirsson TE, Gudbjartsson DF, Surakka I, Vink JM, Amin N, Geller F, Sulem P, Rafnar T, Esko T, Walter S, Gieger C, Rawal R, Mangino M, Prokopenko I, Mägi R, Keskitalo K, Gudjonsdottir IH, Gretarsdottir S, Stefansson H, Thompson JR, Aulchenko YS, Nelis M, Aben KK, den Heijer M, Dirksen A, Ashraf H, Soranzo N, Valdes AM, Steves C, Uitterlinden AG, Hofman A, Tönjes A, Kovacs P, Hottenga JJ, Willemsen G, Vogelzangs N, Döring A, Dahmen N, Nitz B, Pergadia ML, Saez B, De Diego V, Lezcano V, Garcia-Prats MD, Ripatti S, Perola M, Kettunen J, Hartikainen AL, Pouta A, Laitinen J, Isohanni M, Huei-Yi S, Allen M, Krestyaninova M, Hall AS, Jones GT, van Rij AM, Mueller T, Dieplinger B, Haltmayer M, Jonsson S, Matthiasson SE, Oskarsson H, Tyrfingsson T, Kiemeney LA, Mayordomo JI, Lindholt JS, Pedersen JH, Franklin WA, Wolf H, Montgomery GW, Heath AC, Martin NG, Madden PA, Giegling I, Rujescu D, Järvelin MR, Salomaa V, Stumvoll M, Spector TD, Wichmann HE, Metspalu A, Samani NJ, Penninx BW, Oostra BA, Boomsma DI, Tiemeier H, van Duijn CM, Kaprio J, Gulcher JR; ENGAGE Consortium, McCarthy MI, Peltonen L, Thorsteinsdottir U, Stefansson K.

Nat Genet. 2010 May;42(5):448-53. doi: 10.1038/ng.573. Epub 2010 Apr 25.

3.

Finding the missing heritability of complex diseases.

Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, Cho JH, Guttmacher AE, Kong A, Kruglyak L, Mardis E, Rotimi CN, Slatkin M, Valle D, Whittemore AS, Boehnke M, Clark AG, Eichler EE, Gibson G, Haines JL, Mackay TF, McCarroll SA, Visscher PM.

Nature. 2009 Oct 8;461(7265):747-53. doi: 10.1038/nature08494. Review.

4.

Varenicline gets stronger warnings about psychiatric problems, vehicle crashes.

Kuehn BM.

JAMA. 2009 Aug 26;302(8):834. doi: 10.1001/jama.2009.1153. No abstract available.

PMID:
19706852
5.

Genome-wide association studies in pharmacogenomics: untapped potential for translation.

Guessous I, Gwinn M, Khoury MJ.

Genome Med. 2009 Apr 28;1(4):46. doi: 10.1186/gm46.

6.

Genetic risk prediction--are we there yet?

Kraft P, Hunter DJ.

N Engl J Med. 2009 Apr 23;360(17):1701-3. doi: 10.1056/NEJMp0810107. Epub 2009 Apr 15. No abstract available.

PMID:
19369656
7.

Pharmacogenomic genome-wide association studies: lessons learned thus far.

Crowley JJ, Sullivan PF, McLeod HL.

Pharmacogenomics. 2009 Feb;10(2):161-3. doi: 10.2217/14622416.10.2.161. No abstract available.

8.

Genome-wide association for nicotine dependence and smoking cessation success in NIH research volunteers.

Drgon T, Montoya I, Johnson C, Liu QR, Walther D, Hamer D, Uhl GR.

Mol Med. 2009 Jan-Feb;15(1-2):21-7. doi: 10.2119/molmed.2008.00096. Epub 2008 Oct 2.

9.

Molecular genetics of successful smoking cessation: convergent genome-wide association study results.

Uhl GR, Liu QR, Drgon T, Johnson C, Walther D, Rose JE, David SP, Niaura R, Lerman C.

Arch Gen Psychiatry. 2008 Jun;65(6):683-93. doi: 10.1001/archpsyc.65.6.683.

10.

A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25.

Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Chen C, Goodman G, Field JK, Liloglou T, Xinarianos G, Cassidy A, McLaughlin J, Liu G, Narod S, Krokan HE, Skorpen F, Elvestad MB, Hveem K, Vatten L, Linseisen J, Clavel-Chapelon F, Vineis P, Bueno-de-Mesquita HB, Lund E, Martinez C, Bingham S, Rasmuson T, Hainaut P, Riboli E, Ahrens W, Benhamou S, Lagiou P, Trichopoulos D, Holcátová I, Merletti F, Kjaerheim K, Agudo A, Macfarlane G, Talamini R, Simonato L, Lowry R, Conway DI, Znaor A, Healy C, Zelenika D, Boland A, Delepine M, Foglio M, Lechner D, Matsuda F, Blanche H, Gut I, Heath S, Lathrop M, Brennan P.

Nature. 2008 Apr 3;452(7187):633-7. doi: 10.1038/nature06885.

11.

Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.

Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T, Dong Q, Zhang Q, Gu X, Vijayakrishnan J, Sullivan K, Matakidou A, Wang Y, Mills G, Doheny K, Tsai YY, Chen WV, Shete S, Spitz MR, Houlston RS.

Nat Genet. 2008 May;40(5):616-22. doi: 10.1038/ng.109. Epub 2008 Apr 2.

12.

Genetics and smoking cessation improving outcomes in smokers at risk.

Lerman CE, Schnoll RA, Munafò MR.

Am J Prev Med. 2007 Dec;33(6 Suppl):S398-405. Review.

13.

Point: genetic risk feedback for common disease time to test the waters.

McBride CM, Brody LC.

Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1724-6. No abstract available.

14.

The limitations of risk factors as prognostic tools.

Ware JH.

N Engl J Med. 2006 Dec 21;355(25):2615-7. No abstract available.

PMID:
17182986
15.

Novel genes identified in a high-density genome wide association study for nicotine dependence.

Bierut LJ, Madden PA, Breslau N, Johnson EO, Hatsukami D, Pomerleau OF, Swan GE, Rutter J, Bertelsen S, Fox L, Fugman D, Goate AM, Hinrichs AL, Konvicka K, Martin NG, Montgomery GW, Saccone NL, Saccone SF, Wang JC, Chase GA, Rice JP, Ballinger DG.

Hum Mol Genet. 2007 Jan 1;16(1):24-35. Epub 2006 Dec 7.

16.
17.

The use of race variables in genetic studies of complex traits and the goal of reducing health disparities: a transdisciplinary perspective.

Shields AE, Fortun M, Hammonds EM, King PA, Lerman C, Rapp R, Sullivan PF.

Am Psychol. 2005 Jan;60(1):77-103.

PMID:
15641924
18.

Translating emerging research on the genetics of smoking into clinical practice: ethical and social considerations.

Shields A, Lerman C, Sullivan P.

Nicotine Tob Res. 2004 Aug;6(4):675-88. Review.

PMID:
15370164

Supplemental Content

Support Center